Tanaka, Yukie <br/><br/>
BIMEL is a key effector molecule in oxidative stress-mediated apoptosis in acute myeloid leukemia cells when combined with arsenic trioxide and buthionine sulfoximine.  [electronic resource] 

 -  BMC cancer  Jan 2014 
 - 27 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1471-2407 
<br/><br/><label>Standard No.: </label>10.1186/1471-2407-14-27  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Apoptosis--drug effects<br/>Apoptosis Regulatory Proteins--deficiency<br/>Arsenic Trioxide<br/>Arsenicals--administration & dosage<br/>Bcl-2-Like Protein 11<br/>Buthionine Sulfoximine--administration & dosage<br/>Drug Combinations<br/>Gene Knockdown Techniques--methods<br/>HL-60 Cells<br/>Humans<br/>Leukemia, Myeloid, Acute--metabolism<br/>Membrane Proteins--deficiency<br/>Oxidative Stress--drug effects<br/>Oxides--administration & dosage<br/>Phosphorylation--drug effects<br/>Proto-Oncogene Proteins--deficiency